Rhythm Biosciences Limited
Rhythm Biosciences Limited
Your view on RHY.AX
Overview
What the company does, where it operates, and who runs it.
About Rhythm Biosciences Limited
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- David Atkins
- Headquarters
- Bio21 Institute, Parkville, VIC, AU
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- David Atkins
- Headquarters
- Bio21 Institute, Parkville, VIC, AU
Rhythm Biosciences Limited functions as a forward-thinking enterprise focused on predictive cancer diagnostics, active across both Australian and global territories. The company's core operations involve the creation, advancement, and market introduction of cutting-edge medical diagnostic technologies.
A key innovation is ColoSTAT, their specialized blood test designed for the prompt and reliable identification of colorectal cancer. Established in 2017, the firm's main offices are located in Parkville, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Rhythm Biosciences Limited. Starting points for Rhythm Biosciences Limited: EPS -AUD 0.02, beta 0.43 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Rhythm Biosciences Limited. Rhythm Biosciences Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Rhythm Biosciences Limited. Trailing twelve-month EPS for Rhythm Biosciences Limited stands at -AUD 0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Rhythm Biosciences Limited. Rhythm Biosciences Limited has reported as a listed company since 2017. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| THOXFBioPorto A/S | Healthcare | OTC | $73.8M | ||
| TMOThermo Fisher Scientific Inc. | Healthcare | NYSE | $248.1B | ||
| TMO.NEThermo Fisher Scientific Inc. | Healthcare | NEO | — | ||
| TOMDFTodos Medical Ltd. | Healthcare | OTC | $14,081 | ||
| TTOOT2 Biosystems, Inc. | Healthcare | OTC | $11,218 | ||
| TWSTTwist Bioscience Corporation | Healthcare | NASDAQ | $7.0B | ||
| VCYTVeracyte, Inc. | Healthcare | NASDAQ | $2.0B | ||
| VIMGFVimian Group AB (publ) | Healthcare | OTC | $1.5B | ||
| VRCDFVerici Dx plc | Healthcare | OTC | $4.5M | ||
| WATWaters Corporation | Healthcare | NYSE | $43.3B | ||
| WGSGeneDx Holdings Corp. | Healthcare | NASDAQ | $1.4B | ||
| WUXAYWuXi AppTec Co., Ltd. | Healthcare | OTC | $45.6B | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Rhythm Biosciences Limited. Coverage tracks Rhythm Biosciences Limited within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Rhythm Biosciences Limited.